Small Business Innovation Research (SBIR) program, Phase I
ID: HHS-2024-ACL-NIDILRR-BISA-0069Type: Phase I
Overview

Topic

Small Business Innovation Research (SBIR) program, Phase I

Agency

Department of Health and Human ServicesAdministration for Community Living

Program

Type: SBIRPhase: Phase IYear: 2024

Topic Link

https://www.sbir.gov/node/2470499

Additional Information

https://www.grants.gov/web/grants/view-opportunity.html?oppId=349378
Timeline
  1. 1
    Release Oct 19, 2023 12:00 AM
  2. 2
    Open Oct 19, 2023 12:00 AM
  3. 3
    Next Submission Due Dec 18, 2023 12:00 AM
  4. 4
    Close Dec 18, 2023 12:00 AM
Description

The Department of Health and Human Services is seeking proposals for the Small Business Innovation Research (SBIR) program, Phase I. The program is administered by the Administration for Community Living and aims to stimulate technological innovation in the private sector, particularly in meeting the research and development needs related to disabilities. The program aims to improve the lives of people with disabilities through research and development products generated by small businesses. The program will award 11 grants with a project period of 6 months and a corresponding six-month budget period. For more information, please visit the SBIR topic link and the solicitation agency URL.

Files
No associated files provided.
Similar Opportunities
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Innovation Research (SBIR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and tools for monitoring cognitive function. The solicitation is open until September 8, 2025, with multiple application due dates throughout the year. More information can be found on the grants.gov and NIH websites.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The purpose of this funding opportunity is to support small business concerns in developing technologies for commercialization that can fill the service gaps in addressing SUD. The research objectives include developing products that reduce costs, time, and increase access in addressing health-related social needs such as housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The technologies can include physical devices, digital services, software, or non-physical/non-tangible products. The funding opportunity is open for applications until March 14, 2026, and offers both Phase I and Phase II funding options. Phase I focuses on establishing technical merit and feasibility, while Phase II aims to advance technologies towards commercialization. Applicants are encouraged to review the guidelines and adhere to the requirements applicable to their research.
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Technology Transfer (STTR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and genetic analysis tools. The solicitation is open until September 6, 2025, and multiple application due dates are provided. For more information and to apply, visit the SBIR topic link [here](https://www.sbir.gov/node/2230637) and the solicitation agency URL [here](https://grants.nih.gov/grants/guide/PA-files/PAS-22-197.html).
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). The goal of this solicitation is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and educational training programs. The solicitation is open for applications until September 6, 2025, and the funding will be provided through the Small Business Technology Transfer (STTR) program. For more information and to submit a proposal, visit the grants.gov website or the National Institutes of Health's solicitation page.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).